Lucy A. Godley

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Update of germ line <i>RUNX1</i> variant curation rules: version 3.1

  Blood Advances · 2026-04-22

• Clinical significance of mRNA nonstop decay in rare disease diagnosis and recommendations for its application in variant classificationPreprint

  Research Square · 2026-03-26

• Correspondence on “ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)” by Lee et al

  Genetics in Medicine · 2026-03-01 · 1 citations

• Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets

  Leukemia · 2026-02-17

• Outcomes of Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome in Recipients or Donors with Deleterious Likely Germline Variants

  Transplantation and Cellular Therapy · 2026-02-01

• Genetic predisposition to haematopoietic malignancies

  Pathology · 2026-02-01

• Generation of an induced pluripotent stem cell line CGOi001-A from a patient with hereditary thrombocytopenia and a germline ANKRD26 mutation

  Stem Cell Research · 2026-01-31

• Group Authors List 1 from The Global State of Blood Cancers: An Ongoing Challenge

  2026-01-22

• FLT3 as a germ line driver in AML: expanding the landscape of leukemia predisposition

  Blood Neoplasia · 2026-01-14

• Data from The Global State of Blood Cancers: An Ongoing Challenge

  2026-01-12

• Group Authors List 1 from The Global State of Blood Cancers: An Ongoing Challenge

  2026-01-12

• P546: The Genomics-enabled Learning Health Systems (gLHS) Network: Selection of projects to increase adoption of genomic medicine practices in health systems

  Genetics in Medicine Open · 2026-01-01

• Mutant p53 promotes clonal hematopoiesis by generating a chronic inflammatory microenvironment

  Journal of Clinical Investigation · 2025-12-30 · 5 citations

• Supplementary Figure S9: from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Figure S2 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Data: list of figures and tables from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Table S6 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Table S11 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Figure S10 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Figure S3 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11